ATP-binding-cassette transporters and fluconazole-resistance of clinical Candida albicans strains

Academic Journal of Second Military Medical University

Volumn 29, Issue 9, 2008, Pages 1038-1041

  Sun, Wei Wei ^a   Gao, Ping Hui ^a   Wang, Ying ^b   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ABC transporter proteins; Candida albicans; Fluconazole; Fungal drug resistance; Rohdamine 6G

Indexed keywords

ABC TRANSPORTER; CANDIDA DRUG RESISTANCE PROTEIN 1; CANDIDA DRUG RESISTANCE PROTEIN 2; FLUCONAZOLE; FUNGAL RNA; GLUCOSE; MEMBRANE PROTEIN; RHODAMINE 6G; UNCLASSIFIED DRUG;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG TRANSPORT; FUNGAL STRAIN; GENE OVEREXPRESSION; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 54249167145     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2008.01038     Document Type: Article

References (12)

1. Chinese source.
2. White T C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus [J]. Antimicrob Agents Chemother, 1997, 41: 1482-1487.
3. Jha S, Karnani N, Dhar S K, Mukhopadhyay K, Shukla S, Saini P, et al. Purification, characterization of N-terminal nucleotide-binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis[J]. Biochemistry, 2003,42:10822-10832.
4. Loeffler J, Einsele H, Hehart H, Schumacher U, Hrastnik C, Daum G. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains[J]. FEMS Microbiol Lett,2000,185:59-63.
5. Mart K A, Lyons C N, Ha K, Rustad T R, White T C. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans [J]. Antimicrob Agents Chemother, 2001,45: 52-59.
6. Oliver B G, Silver P M, Marie C, Hoot SJ, Leyde S E, White T C. Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi [J]. Microbiology, 2008, 154: 960-970.
7. Rai V, Gaur M, Kumar A, Shukla S, Komath S S, Prasad R. A novel catalytic mechanism for ATP hydrolysis employed by the N-terminal nucleotide-binding domain of Cdr1p, a multidrug ABC transporter of Candida albicans[J]. Biochim Biophys Acta, 2008,34:361-372.
8. Wada S, Niimi M, Niimi K, Holmes A R, Monk B C, Cannon R D, et al. Candida glabrata ATP-binding cassette transporters Cdrlp and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosporylation-dependent pumping properties[J]. J Biol Chem, 2002,277:46809-46821.
9. Mishra N N, Prasad T, Sharma N, Payasi A, Prasad R, Gupta D K, et al. Pathogenicity and drug resistance in Candida albicans and other yeast species [J]. Acta Microbiol Immunol Hung, 2007,54:201-235.
10. Chinese source.
11. Coste A, Selmecki A, Forche A, Diogo D, Bougnoux M E, Berman J, et al. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates [J]. Eukaryot Cell, 2007, 6:1889-1904.
12. Tanabe K, Lamping E, Adachi K, Takano Y, Kawabata K, Shizuri Y, et al. Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium[J]. Biochem Biophys Res Commun, 2007,64:990-995.